Detection rate of contrast-enhanced brain magnetic resonance imaging in patients with cognitive impairment

Introduction The number of brain MRI with contrast media performed in patients with cognitive impairment has increased without universal agreement. We aimed to evaluate the detection rate of contrast-enhanced brain MRI in patients with cognitive impairment. Materials and methods This single-institution, retrospective study included 4,838 patients who attended outpatient clinics for cognitive impairment evaluation and underwent brain MRI with or without contrast enhancement from December 2015 to February 2020. Patients who tested positive for cognitive impairment were followed-up to confirm whether the result was true-positive and provide follow-up management. Detection rate was defined as the proportion of patients with true-positive results and was compared between groups with and without contrast enhancement. Individual matching in a 1:2 ratio according to age, sex, and year of test was performed. Results The overall detection rates of brain MRI with and without contrast media were 4.7% (57/1,203; 95% CI: 3.6%–6.1%) and 1.8% (65/3,635; 95% CI: 1.4%–2.3%), respectively (P<0.001); individual matching demonstrated similar results (4.7% and 1.9%). Among 1,203 patients with contrast media, 3.6% was only detectable with the aid of contrast media. The proportion of patients who underwent follow-up imaging or treatment for the detected lesions were significantly higher in the group with contrast media (2.0% and 0.6%, P < .001). Conclusions Detection rate of brain MRI for lesions only detectable with contrast media in patients with cognitive impairment was not high enough and further study is needed to identify whom would truly benefit with contrast media.

[1]  C. Suh,et al.  Use of “Diagnostic Yield” in Imaging Research Reports: Results from Articles Published in Two General Radiology Journals , 2022, Korean journal of radiology.

[2]  K. Holloway,et al.  ACR Appropriateness Criteria® Dementia. , 2020, Journal of the American College of Radiology : JACR.

[3]  R. Lenkinski Gadolinium Deposition and Retention in the Brain: Should We Be Concerned? , 2019, Radiology. Cardiothoracic imaging.

[4]  R. Hartman,et al.  Acute Adverse Events Following Gadolinium-based Contrast Agent Administration: A Single-Center Retrospective Study of 281 945 Injections. , 2019, Radiology.

[5]  N. Fox,et al.  Incidental findings on brain imaging and blood tests: results from the first phase of Insight 46, a prospective observational substudy of the 1946 British birth cohort , 2019, BMJ Open.

[6]  C. Sudlow,et al.  Potentially serious incidental findings on brain and body magnetic resonance imaging of apparently asymptomatic adults: systematic review and meta-analysis , 2018, British Medical Journal.

[7]  C. Sudlow,et al.  Impact of detecting potentially serious incidental findings during multi-modal imaging , 2018, Wellcome open research.

[8]  John P A Ioannidis,et al.  Prevalence and outcomes of incidental imaging findings: umbrella review , 2018, British Medical Journal.

[9]  Carol Duff,et al.  Dementia: assessment, management and support for people living with dementia and their carers , 2018 .

[10]  H. Lamb,et al.  Incidental findings in research: A focus group study about the perspective of the research participant , 2018, Journal of magnetic resonance imaging : JMRI.

[11]  F. Schneider,et al.  Incidental findings on brain magnetic resonance imaging in the elderly:the PROOF study , 2016, Brain Imaging and Behavior.

[12]  Benjamin F. J. Verhaaren,et al.  Prevalence, Clinical Management, and Natural Course of Incidental Findings on Brain MR Images: The Population-based Rotterdam Scan Study. , 2016, Radiology.

[13]  Joanna M. Wardlaw,et al.  Incidental Findings on Brain MR Imaging in Older Community-Dwelling Subjects Are Common but Serious Medical Consequences Are Rare: A Cohort Study , 2013, PloS one.

[14]  H. Völzke,et al.  Psychosocial consequences and severity of disclosed incidental findings from whole-body MRI in a general population study , 2013, European Radiology.

[15]  Nick C Fox,et al.  EFNS task force: the use of neuroimaging in the diagnosis of dementia , 2012, European journal of neurology.

[16]  E. Walker,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[17]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[18]  Howard J. Rosen,et al.  Neuroimaging in Dementia , 2011, Neurotherapeutics.

[19]  Nick C Fox,et al.  Revising the definition of Alzheimer's disease: a new lexicon , 2010, The Lancet Neurology.

[20]  J T O'Brien,et al.  EFNS guidelines for the diagnosis and management of Alzheimer’s disease , 2010, European journal of neurology.

[21]  Yoshito Tsushima,et al.  Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis , 2009, BMJ : British Medical Journal.

[22]  P. Scheltens,et al.  Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria , 2007, The Lancet Neurology.

[23]  C. Mathers,et al.  Global prevalence of dementia: a Delphi consensus study , 2005, The Lancet.

[24]  L. Beckett,et al.  Annual Incidence of Alzheimer Disease in the United States Projected to the Years 2000 Through 2050 , 2001, Alzheimer disease and associated disorders.

[25]  V. Runge,et al.  Safety of magnetic resonance contrast media. , 2001, Topics in magnetic resonance imaging : TMRI.

[26]  B. Miller,et al.  CME Practice parameter : Diagnosis of dementia ( an evidence-based review ) Report of the Quality Standards Subcommittee of the American Academy of Neurology , 2001 .

[27]  W. Pan Akaike's Information Criterion in Generalized Estimating Equations , 2001, Biometrics.

[28]  V. Runge,et al.  Safety of approved MR contrast media for intravenous injection , 2000, Journal of magnetic resonance imaging : JMRI.

[29]  J. Brunberg,et al.  Adverse reactions to gadolinium contrast media: a review of 36 cases. , 1996, AJR. American journal of roentgenology.

[30]  M. Carter Diagnostic and Statistical Manual of Mental Disorders, 5th ed. , 2014 .

[31]  Anne G. Osborn,et al.  Osborn's brain : imaging, pathology, and anatomy , 2013 .

[32]  J. Stockman Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis , 2011 .

[33]  S. Wiebe,et al.  Report of the Quality Standards Subcommittee of the American Academy of Neurology, in Association with the American Epilepsy Society and the American Association of Neurological Surgeons , 2003 .